Loading...
OTC Markets
Totals
Securities
12,256
Dollar Vol
$2.7B
Share Vol
6.1B
Trades
443,973

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

CPRX
Catalyst Pharmaceuticals, Inc.

Common Stock

19.68

-0.18

-0.91%

Delayed (15 Min) Trade Data: 04:00pm 08/11/2025
Catalyst Pharmaceuticals, Inc. Company Logo

355 Alhambra Circle

Suite 801

Coral Gables, FL 33134

(305) 420-3200

Business Description
Not available
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001369568
Fiscal Year End
12/31
Company Officers & Contacts
Patrick McEnany
CEO

Alicia Grande
CFO

Board of Directors

Not available

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers

Not available

Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
DE, US
Employees
Not Available
Shell
No
Products and Services

Not available

Company Facilities

Not available

Company Notes
Formerly=Catalyst Pharmaceutical Partners, Inc. until 5-2015
Nasdaq
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.